Luda Diatchenko
Luda Diatchenko is an academic and researcher at McGill University in Quebec, Canada, with a research focus on pain in humans.[1] In 2023, she was inducted as a Fellow of the Royal Society of Canada.[2] Her work has covered genetics and pharmaceuticals, including finding that anti-inflammatory drugs can contribute to the development of chronic pain.[3] She had previously worked at the University of North Carolina at Chapel Hill.[4]
Diatchenko holds appointments as the Canada Excellence Research Chair (CERC) in Human Pain Genetics,[4] the Pfizer Canada Professor in Pain Research,[2] and a membership in the Canadian Academy of Health Sciences. In 2019 she received the title of Honourary Skou Professor from Aarhus University.[5]
References[edit]
- ^ "Canadian study offers important clue to why some back pain becomes chronic". CBC News.
- ^ a b "Luda Diatchenko named a Fellow of the Royal Society of Canada". Faculty of Dental Medicine and Oral Health Sciences. Retrieved 2024-04-03.
- ^ Admin (2022-07-26). "McGill study finds anti-inflammatory drugs may lead to chronic pain". The Tribune. Retrieved 2024-04-03.
- ^ a b Mcdevitt, Neale (2013-09-25). "Dr. Luda Diatchenko awarded more than $10 million in federal funding as CERC in Human Pain Genetics". McGill Reporter. Retrieved 2024-04-03.
- ^ "Dr. Diatchenko Receives Honorary Award". Faculty of Dental Medicine and Oral Health Sciences. Retrieved 2024-04-03.
 .svg){kind=small}  | This biography related to medicine in Canada is a stub. You can help Wikipedia by expanding it. |